• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Stryker sues Biomet, sales reps over alleged poaching scheme

Stryker sues Biomet, sales reps over alleged poaching scheme

October 2, 2013 By Brad Perriello

Stryker sues Biomet, sales reps over alleged poaching scheme
Stryker sues Biomet, sales reps over alleged poaching scheme

Stryker (NYSE:SYK) accused Biomet and a pair of former sales representatives of a scheme to poach reps and business from Stryker in Louisiana and New York.

Christopher Ridgeway and Richard Steitzer allegedly conspired with Biomet in the scheme, according to a lawsuit filed Monday in the U.S. District Court for Western Michigan. Steitzer quit in June to work for Biomet; Stryker fired Ridgeway Sept. 10, according to the lawsuit, after discovering that he was allegedly running a pair of medical supply businesses on the side.

"Over the past 2 weeks, Stryker uncovered an ill-conceived and long-planned scheme by Biomet, using Stryker representatives in both New York (Steitzer) and Louisiana (Ridgeway), to erode Stryker’s customer relationships and raid sales teams from Stryker’s Neuro Spine ENT business unit and craniomaxillofacial division. Complete with secret code words, Biomet’s scheme involved Ridgeway and Steitzer as proxies, while still Stryker employees [emphasis in original], to intentionally damage Stryker and sabotage its ability to compete in a highly competitive marketplace," according to the lawsuit.

The lawsuit also accuses Ridgeway of failing to make enough hires to keep his territory competitive, alleging that he turned down 33 applicants for Stryker but hired some for his sideline businesses. Ridgeway made the southern Louisiana branch "so hostile that 4 employees have resigned in the past 20 months, resulting in an 80% turnover rate during that time period," according to the complaint.

"During the course of his September 10, 2013 exit interview, Ridgeway brazenly announced that he devoted only 50% of his time to what he referred to as the ‘Stryker dog and pony show’ and instead parlayed his Stryker contacts to divert opportunities, and potential Stryker employees, to his personal side businesses," according to court documents. "These continuing malicious and opportunistic actions have resulted in the loss of significant business with expected losses exceeding $3 million."

In June, Stryker accused, Biomet began courting Ridgeway, allegedly looking to bring his entire Stryker sales teams on board.

"In June 2013, Ridgeway informed his sales representatives that Biomet expressed interest in bringing the Stryker CMF and NSE sales teams to Biomet and that Biomet would ‘offer us a lot of money,’" according to the documents. "Over the course of the next few months, Ridgeway was in conversations with Biomet regarding moving Stryker business to Biomet. He was nervous about Stryker finding out his plans, and used the code word ‘pancake’ to discuss the business he planned to "’flip.’"

Ridgeway also allegedly induced a 3rd Stryker employee, Sheldon Green, to jump ship for Biomet and forwarded Stryker’ Louisiana customer list to Green, according to the complaint.

Stryker also accused Steitzer of lying about his role at Biomet, saying he accepted severance payments pegged to his agreement not to work for a competing business at Biomet.

"Stryker discovered that not only had Steitzer misappropriated Stryker’s trade secrets and disclosed those trade secrets to Biomet, but Steitzer was further breaching his non-competition and non-solicitation agreement by soliciting and moving Stryker’s business to Biomet. This conduct is even more egregious insomuch as Stryker had, between June and present, been paying Steitzer to sit on the sidelines, per one of the terms contained in the non-compete agreement," according to the lawsuit.

Stryker wants Judge Robert Bell to grant injunctions and a temporary restraining order barring Ridgeway, Steitzer and Biomet from disclosing trade secrets, diverting customers and selling to customers they’ve already allegedly diverted, according to the complaint. Stryker also wants punitive damages and disgorgement of any profits made from the alleged scheme, plus legal costs.

Yesterday Bell denied the bid for a temporary restraining order, scheduling a hearing for Oct. 30 and ordering the defendants to show cause why the injunctions should not be imposed, according to the documents.

"Upon review of plaintiffs’ complaint and motion for temporary restraining order, the court finds that plaintiffs have shown a likelihood of success on the merits of their breach of contract claims. However, the court is not convinced that immediate and irreparable injury, loss, or damage will result to plaintiffs before defendants can be heard in opposition," Bell wrote. "Defendants are now on notice of plaintiffs’ assertions regarding their alleged breaches of their confidentiality agreements and non-compete agreements, and any temporary restraining order would merely require defendants to abide by the terms of those same agreements."

Filed Under: Legal News, News Well Tagged With: Biomet, Personnel Moves, Stryker

More recent news

  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy